நேரடி சோடியம் அகற்றுதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நேரடி சோடியம் அகற்றுதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நேரடி சோடியம் அகற்றுதல் Today - Breaking & Trending Today

Investegate |Sequana Medical NV Announcements | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Investegate |Sequana Medical NV Announcements | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , Guillaume Van Renterghem , Company Or Sequana , Sequana Medical , Euronext Brussels , Belgian Act , Share Options , Executive Share Options , Executive Share Option , Direct Sodium Removal , North American , ஒன்றுபட்டது மாநிலங்களில் , பெல்ஜியன் நாடகம் , பகிர் விருப்பங்கள் , நிர்வாகி பகிர் விருப்பங்கள் , நிர்வாகி பகிர் விருப்பம் , நேரடி சோடியம் அகற்றுதல் , வடக்கு அமெரிக்கன் ,

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Guillaume Van Renterghem , Company Or Sequana , Euronext Brussels , Belgian Act , Share Options , Executive Share Options , Executive Share Option , Direct Sodium Removal , Sequana Medical , North American , Exercise Share , ஒன்றுபட்டது மாநிலங்களில் , பெல்ஜியன் நாடகம் , பகிர் விருப்பங்கள் , நிர்வாகி பகிர் விருப்பங்கள் , நிர்வாகி பகிர் விருப்பம் , நேரடி சோடியம் அகற்றுதல் , வடக்கு அமெரிக்கன் ,

Sequana Medical NV: Sequana Medical's results from RED DESERT alfapump DSR study presented as one of the Highlights at Heart Failure 2021 Online Congress

Sequana Medical NV: Sequana Medical s results from RED DESERT alfapump DSR study presented as one of the Highlights at Heart Failure 2021 Online Congress
the Company or Sequana Medical
), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that the positive results from its RED DESERT study of
alfapump DSR (Direct Sodium Removal) which were presented at the Heart Failure 2021 Online Congress as part of the Late Breaking Science Results were also selected for the congress Highlights session, held virtually on 1 July 2021.
Dr
,
,
at the Heart Failure 2021
Online
a
improvement in diuretic response. ....

United States , Jeffrey Testani , Guillaume Van Renterghem , Online Congress , Company Or Sequana , Euronext Brussels , Direct Sodium Removal , Heart Failure , Late Breaking Science Results , Associate Professor , Heart Failure Research , Yale University School , Sequana Medical , Human Experience , Diuretic Resistant Chronic Heart , North American , ஒன்றுபட்டது மாநிலங்களில் , நிகழ்நிலை காங்கிரஸ் , நேரடி சோடியம் அகற்றுதல் , இதயம் தோல்வி , இணை ப்ரொஃபெஸர் , இதயம் தோல்வி ஆராய்ச்சி , யேல் பல்கலைக்கழகம் பள்ளி , மனிதன் அனுபவம் , வடக்கு அமெரிக்கன் ,

Investegate |Sequana Medical NV Announcements | Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump® study (POSEIDON)

Sequana Medical NV
(Euronext Brussels: SEQUA, the Company or Sequana Medical ), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces positive results from the second interim analysis of POSEIDON, the North American pivotal study of the
alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. These interim data from 26 patients in the Roll-In Cohort are in line with the previous interim data
ii, including positive outcomes against all primary endpoints of the study and a rapid and persistent clinically important improvement in quality of life measures. ....

United States , Cian Crosbie , Florence Wong , Guillaume Van Renterghem , University Of Toronto , Company Or Sequana , Clinical Events Committee , Sequana Medical , North American , Roll In Cohortreconfirm , Euronext Brussels , Roll In Cohort , Pivotal Cohort , Premarket Approval , Chief Executive Officer , Toronto General Hospital , Principal Investigator , Minimal Clinically Important Difference , Clinical Events , Non Alcoholic Steatohepatitis , Direct Sodium Removal , ஒன்றுபட்டது மாநிலங்களில் , ஈயந் க்ராஸ்பி , புளோரன்ஸ் வோங் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , மருத்துவ நிகழ்வுகள் குழு ,

Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump study (POSEIDON)

Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump study (POSEIDON)
i
All patients experienced
Safety
Primary endpoint read-out
Sequana Medical NV
(Euronext Brussels: SEQUA, the Company or Sequana Medical ), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces positive results from the second interim analysis of POSEIDON, the North American pivotal study of the
alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. These interim data from 26 patients in the Roll-In Cohort are in line with the previous interim data ....

United States , Cian Crosbie , Florence Wong , Guillaume Van Renterghem , University Of Toronto , Company Or Sequana , Clinical Events Committee , Roll In Cohortreconfirm , Euronext Brussels , North American , Roll In Cohort , Pivotal Cohort , Premarket Approval , Chief Executive Officer , Sequana Medical , Toronto General Hospital , Principal Investigator , Minimal Clinically Important Difference , Non Alcoholic Steatohepatitis , Direct Sodium Removal , ஒன்றுபட்டது மாநிலங்களில் , ஈயந் க்ராஸ்பி , புளோரன்ஸ் வோங் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , மருத்துவ நிகழ்வுகள் குழு , வடக்கு அமெரிக்கன் ,